Back to Authors

Chang, Julie E.

Mayo Clinic

University of Wisconsin–Madison

Citations 1

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Blood Advances | July 20, 2018 | Volume: 2 | Issue: 14 | Pages: 1705-1718

10.1182/bloodadvances.2017015396 | PMID 30030269

Key PointsBrief lenalidomide consolidation after chemoimmunotherapy is acceptably tolerated and extends PFS and OS in CLL. FCR has superior efficacy compared with FR chemoimmunotherapy for CLL.